Your browser doesn't support javascript.
loading
The Application of Nanotechnology in Immunotherapy based Combinations for Cancer Treatment.
Li, Hongxia; Fu, Qiuxia; Muluh, Tobias Achu; Shinge, Shafiu A Umar; Fu, Shaozhi; Wu, JingBo.
Afiliação
  • Li H; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
  • Fu Q; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
  • Muluh TA; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
  • Shinge SAU; Key Laboratory for Biorheological Science and Technology of Ministry of Education, Bioengineering College of Chongqing University, Chongqing, China.
  • Fu S; Department of Cardiovascular Surgery, The Affiliated Hospital of Southwest Medical University, China.
  • Wu J; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Article em En | MEDLINE | ID: mdl-35260063
ABSTRACT
There has been a great amount of advancement in the early field of nano-immunotherapy and combination therapy. Persistent consideration regarding the clinical challenges and therapeutic hindrance should be tended to achieve therapeutic efficacy and potential. In this review, we will address how nanotechnology could defeat the difficulties resulting from cancer immunotherapy, how nanoparticles' utilization can enhance the efficacy of immune checkpoint blockers, and reconstituting the tumor microenvironment can promote antitumor responses. Moreover, this review discusses how nanoparticles mediate therapeutic modalities like chemotherapy, photodynamic therapy, photothermal therapy, and radiotherapy, which are used to target and destroy cancerous cells, initiate the release of tumor antigens, and can trigger anti-tumor immunity reactions. Furthermore, we analyzed the potential benefits of immunotherapy combinatorial using the nanoparticle delivery system to prevent tumor recurrence, hinder metastases, and decrease systemic toxicity of major organs and healthy cells common with uncontrolled targeting.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanotecnologia / Imunoterapia / Neoplasias Limite: Humans Idioma: En Revista: Recent Pat Anticancer Drug Discov Assunto da revista: NEOPLASIAS / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanotecnologia / Imunoterapia / Neoplasias Limite: Humans Idioma: En Revista: Recent Pat Anticancer Drug Discov Assunto da revista: NEOPLASIAS / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
...